STAT5A and breast cancer: The absence of detectable Nuc-Stat5a in these tumors indicated a significantly increased risk of breast cancer-specific death (CSS; log-rank P < 0.001; n = 73; Figure 3A; univariate Cox regression HR = 6.73 (1.88, 24.05); P = 0.003; n = 73).